Pyxis Oncology
PYXS
PYXS
77 hedge funds and large institutions have $40.5M invested in Pyxis Oncology in 2026 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 11 increasing their positions, 36 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
3% less funds holding
Funds holding: 79 → 77 (-2)
4.63% less ownership
Funds ownership: 48.5% → 43.86% (-4.6%)
69% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 36
Holders
77
Holding in Top 10
2
Calls
$290K
Puts
$10K
Top Buyers
| 1 | +$695K | |
| 2 | +$303K | |
| 3 | +$242K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$217K |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$105K |
Top Sellers
| 1 | -$861K | |
| 2 | -$726K | |
| 3 | -$633K | |
| 4 |
Millennium Management
New York
|
-$521K |
| 5 |
ECM
ExodusPoint Capital Management
New York
|
-$365K |
